Adenylate kinase 3 pseudogene 2 (AK3P2)

AK3 pseudogene 2 (AK3P2) is a processed pseudogene in the human genome, annotated by the HUGO Gene Nomenclature Committee (HGNC). It is homologous to the protein-coding adenylate kinase 3 (AK3) gene but does not encode a functional protein due to mutations or processing events[1][3][5][7][9]. Pseudogenes such as AK3P2 are typically regarded as non-coding and non-functional; however, some pseudogenes may play regulatory roles or participate in gene expression modulation through RNA-mediated mechanisms[4][10]. There is no evidence that AK3P2 itself is an active therapeutic target, a receptor, or an enzyme, nor any reported drug interactions, specific biological functions, or disease implications tied directly to AK3P2. Clarifications and Limitations: - Not a therapeutic target: AK3P2 is a pseudogene, which means it does not encode a functional protein; thus, it is not considered a therapeutic target or druggable entity[1][3][5][7][9]. - Nomenclature correctness: The provided names (AK3P2, AK3 pseudogene 2, HsT26053) are correct and consistent with public gene nomenclature databases[1][3][5][7][9]. - Missing information: There is no known functional, biomarker, or disease-association data for AK3P2 specifically, so related categories are left null or indicated as such. Summary: AK3P2 (Adenylate kinase 3 pseudogene 2) is a processed pseudogene in humans, not a protein-coding gene, not considered a therapeutic target, and not currently known to have biological function or disease association in its own right[1][3][5][7][9].

Other names

HsT26053AK3 pseudogene 2adenylate kinase 3 pseudogene 2RNR2